Come up with a name for your new list and we'll add to it:
Vivreon Biosciences raised a round of funding on September 22, 2016. Investors include
Alzheimer's Drug Discovery Foundation.
Vivreon Biosciences is a pre-clinical therapeutics company developing a new class of small molecule therapeutics for the treatment of chronic inflammatory diseases. The company's candidate therapies d…